ELUT NASDAQ
Elutia Inc
1W: -5.0%
1M: -7.9%
3M: -17.8%
YTD: +21.1%
1Y: -12.0%
3Y: -39.2%
5Y: -89.9%
$0.78
-0.02 (-2.66%)
Weekly Expected Move ±6.7%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
11 relationships11
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2023-04-21
Earliest Filing
2025-10-07
Latest Filing
partner: 5
acquirer: 5
customer: 1
Counterparties (Filed by ELUT)
11 relationshipsCompanies named in ELUT's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Ligand Pharmaceuticals Incorporated | LGNZZ | partner | Counterparty to royalty agreement amendment and asset sale | 2025-10-07 | View |
| Boston Scientific Corporation | BSX | acquirer | Buyer of CIED Business assets | 2025-10-07 | View |
| Cardiac Pacemakers, Inc. | — | acquirer | Buyer of CIED Business assets | 2025-10-07 | View |
| Boston Scientific Corporation | BSX | acquirer | Acquired the Cardiac Implantable Electronic Device Business from Elutia Inc. | 2025-09-09 | View |
| Cardiac Pacemakers Inc. | CPI | acquirer | Jointly acquired the Cardiac Implantable Electronic Device Business from Elutia Inc. | 2025-09-09 | View |
| Ligand Pharmaceuticals Incorporated | LGNZZ | partner | Counterparty to royalty agreement amendment where Elutia issued shares to satisfy outstanding royalty obligations. | 2025-05-08 | View |
| Lake Street Capital Markets, LLC | — | partner | Placement agent for the registered direct offering of Class A common stock and prefunded warrants. | 2025-02-04 | View |
| Ligand Pharmaceuticals Incorporated | LGNZZ | partner | Elutia Med entered into an Amendment to a Royalty Agreement with Ligand Pharmaceuticals Incorporated. | 2024-01-12 | View |
| Berkeley Biologics, LLC | — | acquirer | Acquired substantially all assets related to Elutia's Orthobiologics business and contract manufacturing. | 2023-09-19 | View |
| GNI Group, Ltd. | 2160.T | partner | Parent company of Berkeley Biologics, LLC, acting as a guarantor in the purchase agreement. | 2023-09-19 | View |
| LeMaitre Vascular, Inc. | LMAT | customer | Aziyo appointed LeMaitre as its exclusive distributor for specific product lines in the United States. | 2023-04-21 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-21 | Acquisition/Disposition; Regulation FD; Exhibits | Acquisition | View |
| 2026-08-13 | Earnings Release; Exhibits | View | |
| 2026-08-07 | Delisting Notice; Exhibits | View | |
| 2026-07-20 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-06-16 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-03-11 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-03-09 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2026-03-04 | Other Events; Financial Statements and Exhibits | View | |
| 2026-01-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-02 | Notice of Delisting or Transfer; Financial Statements and Exhibits | View | |
| 2025-11-12 | Notice of Delisting or Transfer; Financial Statements and Exhibits | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-14 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-10-07 | Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Regula | Agreement Acquisition | View |
| 2025-09-09 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2025-08-20 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2025-08-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-04 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-08 | Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Unregistere | Agreement | View |
| 2025-05-06 | Termination of Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exh | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR